FBXO32 and cancer: In agreement with data from our study, preclinical cancer cachexia studies consistently show significant overexpression of Atrogin1 and MuRF1 in skeletal muscle tissue of cachectic animals and C2C12 immortalized mouse myoblast cells treated in vitro with TNFα [40,42].